Related references
Note: Only part of the references are listed.Continuous Subcutaneous Levodopa Delivery for Parkinson's Disease: A Randomized Study
C. Warren Olanow et al.
JOURNAL OF PARKINSONS DISEASE (2021)
Impact of Insulin Injection and Infusion Routines on Lipohypertrophy and Glycemic Control in Children and Adults with Diabetes
Asma Deeb et al.
DIABETES THERAPY (2019)
Developing consensus among movement disorder specialists on clinical indicators for identification and management of advanced Parkinson's disease: a multi-country Delphi-panel approach
Angelo Antonini et al.
CURRENT MEDICAL RESEARCH AND OPINION (2018)
Practical management of adverse events related to apomorphine therapy
Roongroj Bhidayasiri et al.
PARKINSONISM & RELATED DISORDERS (2016)
Effective Delivery of Apomorphine in the Management of Parkinson Disease: Practical Considerations for Clinicians and Parkinson Nurses
Roongroj Bhidayasiri et al.
CLINICAL NEUROPHARMACOLOGY (2015)
Questionnaire for impulsive-compulsive disorders in Parkinson's Disease-Rating Scale
Daniel Weintraub et al.
MOVEMENT DISORDERS (2012)
The Columbia-Suicide Severity Rating Scale: Initial Validity and Internal Consistency Findings From Three Multisite Studies With Adolescents and Adults
Kelly Posner et al.
AMERICAN JOURNAL OF PSYCHIATRY (2011)
Determination of Minimal Clinically Important Change in Early and Advanced Parkinson's Disease
Robert A. Hauser et al.
MOVEMENT DISORDERS (2011)
Technical risks with subcutaneous insulin infusion
I Guilhem et al.
DIABETES & METABOLISM (2006)
Parkinson's disease home diary: Further validation and implications for clinical trials
RA Hauser et al.
MOVEMENT DISORDERS (2004)
Excessive daytime sleepiness in Parkinson's disease as assessed by Epworth Sleepiness Scale (ESS)
S Kumar et al.
SLEEP MEDICINE (2003)
A home diary to assess functional status in patients with Parkinson's disease with motor fluctuations and dyskinesia
RA Hauser et al.
CLINICAL NEUROPHARMACOLOGY (2000)
Share Paper
